Anbio Biotechnology (NNNN) Preferred Shares (2024 - 2025)
Anbio Biotechnology (NNNN) posted Preferred Shares of $4389.0 for Q4 2025, up 3.78% on a QoQ basis from $4229.0 in Q4 2024, and up 3.78% year-over-year from $4229.0 in Q4 2024.
Powered by 
Analysis
Anbio Biotechnology (NNNN) Preferred Shares (2024 - 2025) Analysis & Trends
Anbio Biotechnology has reported Preferred Shares for 2 years, with the latest figure at $4389.0 in Q4 2025.
- On a quarterly basis, Preferred Shares rose 3.78% year-over-year to $4389.0 in Q4 2025; TTM through Dec 2025 was $4389.0, a 3.78% increase from a year earlier, with the FY2025 full-year figure at $4389.0, up 3.78% from the prior year.
- Preferred Shares was $4389.0 for Q4 2025 at Anbio Biotechnology, up from $4229.0 in the prior quarter.
- The five-year high for Preferred Shares was $4389.0 in Q4 2025, with the low at $4229.0 in Q4 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | GE HealthCare Technologies | 28.97 Bn | 27.09 Bn | 2.18 Bn | - |
| 2 | Lantheus Holdings | 6.56 Bn | 5.97 Bn | 241.86 Mn | - |
| 3 | Heartflow | 4.40 Bn | 4.03 Bn | 53.19 Mn | - |
| 4 | Neogen | 2.83 Bn | 2.64 Bn | 107.80 Mn | - |
| 5 | Butterfly Network | 1.88 Bn | 1.75 Bn | 23.29 Mn | - |
| 6 | Ceribell | 931.50 Mn | 802.24 Mn | 25.94 Mn | - |
| 7 | Varex Imaging | 779.32 Mn | 694.02 Mn | 76.70 Mn | - |
| 8 | Anbio Biotechnology | 755.43 Mn | 743.53 Mn | - | 4,389.00 |
| 9 | QuidelOrtho | 725.35 Mn | 601.95 Mn | - | - |
| 10 | Prenetics Global | 339.92 Mn | 280.78 Mn | 30.20 Mn | - |